BackOSE Immunotherapeutics S.A. Overview

OSE Immunotherapeutics S.A. Other Liabilities

Track OSE Immunotherapeutics S.A.'s other liabilities ($0) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Other Liabilities
$0.00

Peer average

Loading

OSE Immunotherapeutics S.A. Other Liabilities History

Loading

OSE Immunotherapeutics S.A. vs. peers: Other Liabilities Comparison

Loading

OSE Immunotherapeutics S.A. Other Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

OSE Immunotherapeutics S.A. (ORPOF) FAQ

OSE Immunotherapeutics S.A.'s other liabilities stands at $0 as of December 2025. In the prior-year period, the figure was $0. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

OSE Immunotherapeutics S.A. reported $0 in other liabilities versus $0 a year earlier. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

In the prior-year period, the figure was $0. Sustained growth in other liabilities can support a stronger franchise, while sharp declines may reflect divestitures, weaker demand, or accounting changes. Always read YoY moves with the footnotes of recent filings in mind.

The history chart shows how OSE Immunotherapeutics S.A.'s other liabilities evolved across reporting periods, while the comparison chart places ORPOF next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.

Yes — within Healthcare, other liabilities is commonly used to spot outliers. OSE Immunotherapeutics S.A.'s reading of $0 is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.